Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ANEUFIX for Endoleak Type II Repair

NCT: NCT03918460 · ACTIVE_NOT_RECRUITING

NCT IDNCT03918460
StatusACTIVE_NOT_RECRUITING
Start Date2020-05-13
Completion2028-03-24
SponsorTripleMed B.V. (INDUSTRY)
First posted
Last updated

Brief Summary

The study is non-randomized, multicenter international safety, performance and clinical benefit outcome assessment of ANEUFIX to treat patients with isolated type II endoleak in the presence of a growing AAA-sac following an EVAR procedure more than 6 months ago.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑